Study of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer Confined to the Chest and Previously Operated on Who Were Not Disease-free.

NCT06431633 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

129

Enrollment

OTHER

Sponsor class

Conditions

Lung Diseases
Carcinoma, Non-Small-Cell Lung
Resectable Lung Non-Small Cell Carcinoma

Interventions

DRUG: Zimberelimab
DRUG: Sacituzumab govitecan
DRUG: Cisplatin
DRUG: Carboplatin

Sponsor

Fundación GECP